Literature DB >> 21494532

Brachial approach to NOGA-guided procedures: electromechanical mapping and transendocardial stem-cell injections.

Marko Banovic1, Miodrag C Ostojic, Jozef Bartunek, Milan Nedeljkovic, Branko Beleslin, Andre Terzic.   

Abstract

Several methods are available for delivering stem cells to the heart. Recent studies have highlighted the advantages of injecting the cells directly into the myocardium in order to increase myocardial retention of cells. A particular focus has been on percutaneous transendocardial injection, facilitated by electromechanical mapping.The NOGA XP Cardiac Navigation System has a multicomponent catheter that is designed to guide and deliver transendocardial injections via a transfemoral approach, without a guidewire. However, this method may not be feasible in some patients who have peripheral vascular disease. Herein, we describe the case of a 68-year-old man whose tortuous, sharply angled iliac arteries precluded a femoral approach to transendocardial injection. To overcome the anatomic and mechanical challenges, we used a brachial approach. We believe that this is the 1st report of using the brachial route for transendocardial injection, and that it can be a viable alternative to the transfemoral approach in selected patients.

Entities:  

Keywords:  Biological products/therapeutic use; coronary vessels/pathology; electrophysiologic techniques, cardiac/instrumentation/methods; heart diseases/therapy; imaging, three-dimensional; injections; myocardial infarction/pathology; regenerative medicine/methods; stem cell transplantation/methods; treatment outcome

Mesh:

Year:  2011        PMID: 21494532      PMCID: PMC3066826     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  11 in total

Review 1.  Endoventricular electromechanical mapping-the diagnostic and therapeutic utility of the NOGA XP Cardiac Navigation System.

Authors:  Peter J Psaltis; Stephen G Worthley
Journal:  J Cardiovasc Transl Res       Date:  2008-12-10       Impact factor: 4.132

Review 2.  Intramyocardial navigation and mapping for stem cell delivery.

Authors:  Peter J Psaltis; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley
Journal:  J Cardiovasc Transl Res       Date:  2009-10-23       Impact factor: 4.132

Review 3.  Methods of stem cell delivery in cardiac diseases.

Authors:  Emerson C Perin; Javier López
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2006-03

4.  Stem cells: biologics for regeneration.

Authors:  Tj Nelson; A Behfar; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2008-08-13       Impact factor: 6.875

5.  Stem cell platforms for regenerative medicine.

Authors:  Timothy J Nelson; Atta Behfar; Satsuki Yamada; Almudena Martinez-Fernandez; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

6.  Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.

Authors:  Jens Kastrup; Erik Jørgensen; Andreas Rück; Kristina Tägil; Dietmar Glogar; Witold Ruzyllo; Hans Erik Bøtker; Dariusz Dudek; Viktor Drvota; Birger Hesse; Leif Thuesen; Pontus Blomberg; Mariann Gyöngyösi; Christer Sylvén
Journal:  J Am Coll Cardiol       Date:  2005-04-05       Impact factor: 24.094

7.  Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction.

Authors:  Emerson C Perin; Guilherme V Silva; Joao A R Assad; Deborah Vela; L Maximilian Buja; Andre L S Sousa; Silvio Litovsky; Jing Lin; William K Vaughn; Stephanie Coulter; Marlos R Fernandes; James T Willerson
Journal:  J Mol Cell Cardiol       Date:  2007-10-04       Impact factor: 5.000

Review 8.  Cardiac cell repair therapy: a clinical perspective.

Authors:  Bernard J Gersh; Robert D Simari; Atta Behfar; Carmen M Terzic; Andre Terzic
Journal:  Mayo Clin Proc       Date:  2009-10       Impact factor: 7.616

9.  Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction: first-in-man study.

Authors:  K Krause; K Jaquet; C Schneider; S Haupt; M V Lioznov; K-M Otte; K-H Kuck
Journal:  Heart       Date:  2009-03-30       Impact factor: 5.994

10.  One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study).

Authors:  Nabil Dib; Jonathan Dinsmore; Zaki Lababidi; Bee White; Susan Moravec; Ann Campbell; Amy Rosenbaum; Katayoun Seyedmadani; Wael A Jaber; Craig S Rizenhour; Edward Diethrich
Journal:  JACC Cardiovasc Interv       Date:  2009-01       Impact factor: 11.195

View more
  6 in total

1.  Locked Nucleic Acid AntimiR Therapy for the Heart.

Authors:  Sabine Samolovac; Rabea Hinkel
Journal:  Methods Mol Biol       Date:  2022

2.  The effect of bone marrow- and adipose tissue-derived mesenchymal stem cell transplantation on myocardial remodelling in the rat model of ischaemic heart failure.

Authors:  Andrey A Karpov; Yulia K Uspenskaya; Sarkis M Minasian; Maxim V Puzanov; Renata I Dmitrieva; Anna A Bilibina; Sergey V Anisimov; Michael M Galagudza
Journal:  Int J Exp Pathol       Date:  2013-04-08       Impact factor: 1.925

3.  The Use of Gene Therapy for Ablation of Atrial Fibrillation.

Authors:  Zhao Liu; J Kevin Donahue
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-11-29

4.  Translational Studies on the Potential of a VEGF Nanoparticle-Loaded Hyaluronic Acid Hydrogel.

Authors:  Joanne O'Dwyer; Robert Murphy; Arlyng González-Vázquez; Lenka Kovarova; Martin Pravda; Vladimir Velebny; Andreas Heise; Garry P Duffy; Sally Ann Cryan
Journal:  Pharmaceutics       Date:  2021-05-22       Impact factor: 6.321

Review 5.  Recent advances in gene therapy for atrial fibrillation.

Authors:  Shin Yoo; Gail Elizabeth Geist; Anna Pfenniger; Markus Rottmann; Rishi Arora
Journal:  J Cardiovasc Electrophysiol       Date:  2021-07-06       Impact factor: 2.942

Review 6.  Adult Stem Cell Therapy for Cardiac Repair in Patients After Acute Myocardial Infarction Leading to Ischemic Heart Failure: An Overview of Evidence from the Recent Clinical Trials.

Authors:  Rygiel Katarzyna
Journal:  Curr Cardiol Rev       Date:  2017
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.